Vanda Pharmaceuticals Inc. (VNDA) › Shareholders' EquityVanda Pharmaceuticals Inc. (VNDA) — Shareholders' EquityAnnual figures by period end, from SEC filings.2008-12-31: $46.02M2009-12-31: $23.03M2010-12-31: $37.73M2011-12-31: $33.47M2012-12-31: $9.90M2013-12-31: $44.12M2014-12-31: $160.82M2015-12-31: $133.03M2016-12-31: $131.33M2017-12-31: $131.39M2018-12-31: $275.42M2019-12-31: $410.94M2020-12-31: $453.27M2021-12-31: $504.93M2022-12-31: $527.20M2023-12-31: $544.91M2024-12-31: $538.55M2025-12-31: $327.19M$327.19M2008-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$327.19M-39.2%2026-02-12Balance as of period end2024-12-31$538.55M-1.2%2026-02-12Balance as of period end2023-12-31$544.91M+3.4%2026-02-12Balance as of period end2022-12-31$527.20M+4.4%2026-02-12Balance as of period end2021-12-31$504.93M+11.4%2025-02-14Balance as of period end2020-12-31$453.27M+10.3%2024-02-08Balance as of period end2019-12-31$410.94M+49.2%2023-02-09Balance as of period end2018-12-31$275.42M+109.6%2022-02-24Balance as of period end2017-12-31$131.39M+0.0%2021-02-11Balance as of period end2016-12-31$131.33M-1.3%2020-02-26Balance as of period end2015-12-31$133.03M-17.3%2019-02-19Balance as of period end2014-12-31$160.82M+264.5%2018-02-15Balance as of period end2013-12-31$44.12M+345.5%2017-02-17Balance as of period end2012-12-31$9.90M-70.4%2016-02-12Balance as of period end2011-12-31$33.47M-11.3%2015-03-13Balance as of period end2010-12-31$37.73M+63.8%2014-02-25Balance as of period end2009-12-31$23.03M-50.0%2013-02-26Balance as of period end2008-12-31$46.02M—2012-03-09Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)